Overview

Nerveblocks for Persistent Pain After Breast Cancer Surgery

Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
0
Participant gender:
Female
Summary
Persistent pain after breast cancer surgery (PPBCS) affects 25-60% of breast cancer survivors and nerve damage has been implicated as the cause of this neuropathic pain condition. Local anaesthetic blockade of tenderpoints and the intercostobrachial nerve (ICBN) could provide clues to pathophysiological mechanisms as well as aiding diagnosis and treatment of PPBCS but has never been attempted. The aims of this study is to examine clinical effect of ultrasound guided blockades of the ICBN and tenderpoints of pain.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kenneth Geving Andersen
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

- At least 1 year after surgery for breast cancer

- Women aged 18 or over

- Suffering from persistent pain in the breast, side of chest, axilla or arm (NRS 4 or
over)

Exclusion Criteria:

- Previous cosmetic surgery

- bilateral cancer

- pregnant or lactating

- other disease in the nervous system

- in treatment for psychiatric disease

- unable to understand Danish

- unable to give informed concent